GdGadoliniumOxide.comGd₂O₃ technical reference
Home / Safety
Safe handling

Gadolinium oxide safety & handling

Use the current supplier SDS for the exact grade and jurisdiction. This page explains common powder-handling principles and key distinctions, not a substitute for your workplace risk assessment.

Reviewed: 6 September 2026 · Source-linked technical synthesis
Current SDS example: Thermo Fisher’s U.S. SDS revised 22 December 2025 classifies its gadolinium oxide product as causing serious eye irritation (Category 2). Classifications can vary by jurisdiction, formulation and revision, so always use the SDS supplied with your material.

Primary practical risks for powder handling

  • Avoid generating or inhaling airborne dust.
  • Prevent eye contact; use suitable eye protection where dust or splashes are possible.
  • Use gloves and protective clothing appropriate to the task and local risk assessment.
  • Provide local exhaust or other engineering controls for dust-generating operations.
  • Wash hands after handling and before eating, drinking or smoking.

Storage

Store in a tightly closed, correctly labeled container in a dry area, segregated according to the SDS and your facility chemical-management rules. For high-purity material, contamination control may be as important as chemical stability.

Spill response

Avoid dry sweeping that creates dust. Follow the SDS, facility procedure and local environmental rules. Suitable HEPA-filtered collection or carefully controlled wet methods may be appropriate depending on scale and equipment.

Medical-use misconception

Gadolinium is familiar because of gadolinium-based MRI contrast agents. Industrial Gd₂O₃ powder is not an injectable contrast agent. Even research nanoparticles require engineered coatings, biological testing and regulatory controls.

Transportation and regulatory status

Do not infer shipping classification from a generic web page. Use the current SDS and shipping regulations for the specific product, concentration, package, origin and destination. Supplier SDS Section 14 is the starting point, but shipper responsibilities remain jurisdiction-specific.

References

  1. PubChem. “Gadolinia / Gadolinium oxide (Gd₂O₃), CID 159427.” Molecular formula, molecular weight, identifiers and safety data. pubchem.ncbi.nlm.nih.gov.
  2. NIST Chemistry WebBook. “digadolinium trioxide.” Formula, molecular weight and CAS Registry Number. webbook.nist.gov.
  3. NIST Center for Neutron Research. “Neutron Scattering Lengths and Cross Sections.” Includes absorption cross sections for ¹⁵⁵Gd and ¹⁵⁷Gd. ncnr.nist.gov.
  4. U.S. Geological Survey. Mineral Commodity Summaries 2026 - Rare Earths. Supply and end-use context for rare-earth materials. usgs.gov.
  5. Thermo Fisher Scientific Chemicals. Gadolinium(III) oxide product specifications and SDS, CAS 12064-62-9. thermofisher.com.
  6. American Elements. Gadolinium oxide technical data including density and melting point. americanelements.com.
  7. Recent Progress in Gd-Containing Materials for Neutron Shielding Applications: A Review. Open-access review discussing Gd₂O₃ in glass, polymers, concrete and metals. PMC.
  8. Review on the synthesis, structural and photo-physical properties of Gd₂O₃ phosphors for various luminescent applications. Optik. ScienceDirect.
  9. Current Status and Future Aspects of Gadolinium Oxide Nanoparticles as Positive MRI Contrast Agents. Nanomaterials (2025). Research context and clinical-translation caveats. MDPI.
  10. Atomic Layer Deposition of Gd₂O₃ and Dy₂O₃. Chemistry of Materials. Thin-film structure and electrical-property research. ACS Publications.